As of October 26, 2022, the World Health Organization (WHO) reports 6,883 cases of monkeypox in Africa. This includes 891 confirmed and 5,992 suspected cases. Sadly, 173 deaths have been recorded, with a fatality rate of 2.5%. The virus has spread to eight African Union (AU) Member States and five non-endemic Member States. The latest data shows a worrying increase in cases. This has led the WHO Director-General to think about forming a group to decide if it’s a global health emergency.
In South Africa, between May and July 2024, there were 20 confirmed monkeypox cases. This led to a 15% death rate. Most cases were in Gauteng, followed by KwaZulu-Natal, and then Western Cape. Interestingly, 11 of the first 16 cases were men who have sex with men (MSM). Also, 15 of the confirmed cases were HIV-positive.
The situation with monkeypox in Africa is very concerning. The number of cases and deaths is rising. Health experts are watching the virus closely and working hard to stop its spread.
Key Takeaways
- Africa has reported 6,883 monkeypox cases (891 confirmed, 5,992 suspected) and 173 deaths as of October 2022.
- The recent South Africa outbreak saw 20 confirmed cases with a 15% case fatality ratio, primarily affecting men who have sex with men and individuals living with HIV.
- The WHO is considering declaring the monkeypox situation in Africa a global emergency due to the alarming spread of the virus.
- Public health authorities are responding with surveillance, containment measures, and efforts to improve access to vaccines and treatments.
- Continued monitoring and a coordinated global response are crucial to address the evolving monkeypox crisis in Africa.
Overview of the Monkeypox Situation in Africa
The monkeypox outbreak in Africa has been a big worry for public health lately. By October 2022, it was found in 13 countries in the Africa Union. These countries are Benin, Cameroon, Central African Republic, Congo, Democratic Republic of the Congo, Egypt, Ghana, Liberia, Morocco, Mozambique, Nigeria, Sudan, and South Africa.
Monkeypox Cases and Deaths Reported
Since early 2022, Africa has seen 6,883 monkeypox cases. Out of these, 891 were confirmed and 5,992 were suspected. Sadly, 173 people died, making the death rate 2.5%. Most cases came from the Democratic Republic of Congo, Nigeria, and Ghana.
These countries saw a big jump in cases and deaths compared to last year. The number of cases went up by 160%, and deaths by 19%.
Geographic Distribution of Outbreaks
Now, monkeypox is found in 10 African countries this year. Before 2022, 11 countries had reported monkeypox cases. These countries include Benin, Cameroon, Central African Republic, Congo, Côte d’Ivoire, DRC, Gabon, Liberia, Nigeria, Sierra Leone, and South Sudan.
The African rope squirrel is thought to carry the monkeypox virus in these areas. This makes it a key animal in the spread of the disease.
| Country | Confirmed Cases | Suspected Cases | Deaths |
|---|---|---|---|
| Democratic Republic of Congo | 184 | 3,884 | 154 |
| Nigeria | 552 | 720 | 7 |
| Ghana | 105 | 430 | 4 |
| Other African Countries | 50 | 958 | 8 |
Epidemiology and Transmission of Monkeypox
The monkeypox virus (MPXV) is causing the recent outbreaks. It’s part of the Poxviridae family and has two main types. As of May 21, 2022, 92 confirmed cases and 28 suspected ones were found in 12 countries. No deaths were reported.
Monkeypox spreads through close contact with infected fluids or droplets. Most cases are in men who have sex with men (MSM) and were found in clinics. The virus has two main types, one with a 3.6% death rate and another with a 10.6% rate.
The time it takes to show symptoms is 5 to 21 days, usually around 6 to 13 days. More areas are now watching for monkeypox cases. Experts are talking about how to use vaccines to fight the outbreak.
| Monkeypox Clade | Case Fatality Rate |
|---|---|
| West African Clade | Approximately 3.6% |
| Congo Basin Clade | Approximately 10.6% |
« The identification of monkeypox cases without direct travel links to endemic areas is considered a highly unusual event, marking the need for a comprehensive public health response. »
Monkeypox Symptoms and Clinical Manifestations
Monkeypox is a viral disease that has recently caught the world’s attention. It shows unique symptoms. People with the virus often get a fever and muscle aches. They may also have a sore throat and a skin rash that starts within a week of getting infected.
The rash can show up 1–21 days after exposure. It begins as flat, red spots that turn into raised, fluid-filled blisters. These can be painful and scab over, healing in 2–4 weeks. But, if someone’s immune system is weak, symptoms might last longer.
Distinguishing Monkeypox from Other Diseases
It’s important to tell monkeypox apart from other skin conditions like chickenpox or measles. Testing in a lab is key for a correct diagnosis, especially at the start of an outbreak. The rash’s unique look and other symptoms help doctors suspect monkeypox early. But, a lab test is needed to confirm it.
Treatment Options for Monkeypox
Treatment for monkeypox aims to manage symptoms, take care of the skin, reduce pain, and prevent complications. For severe cases or those at high risk, antiviral drugs like tecovirimat might be given.
« Monkeypox is a serious disease that requires prompt medical attention, but with proper care and treatment, most people recover within a few weeks. »
Public Health Response to Monkeypox Outbreaks
The recent rise in monkeypox cases has led to a global health crisis. In Africa, where the virus is common, many steps have been taken to stop its spread. These efforts aim to manage the outbreaks effectively.
Coordination and Incident Management
A team called the monkeypox Incident Management Team (IMT) has been set up at the national level. This team meets every two weeks. They work together with health experts, healthcare workers, and government agencies to fight the virus.
Surveillance and Contact Tracing
Keeping an eye on the disease and tracing contacts is key to fighting monkeypox. Teams are on the ground to investigate outbreaks. They also send out weekly reports to track the situation. New guidelines for testing have been shared to help with quicker and more accurate results.
Laboratory Testing and Capacity Building
Getting accurate tests quickly is vital. Now, all samples go through the NHLS network to the NICD for testing. Plans are also to use private labs and check wastewater to find more cases.
| Metric | Value |
|---|---|
| Monkeypox Cases Reported Globally | Over 20,000 |
| Monkeypox Cases Reported in Africa | Over 1,800 suspected, less than 200 confirmed |
| Monkeypox Vaccine Doses Distributed | Over 750,000 in the U.S. and Spain |
| Monkeypox Case Fatality Rate in Africa | 3.7% in 2022 |
These efforts, with ongoing monitoring, testing, and building up capacity, aim to improve the fight against monkeypox in Africa and worldwide.
Case Management and Clinical Guidelines
Healthcare teams across Africa are now using strong monkeypox case management and clinical guidelines. These steps help stop the virus from spreading and treat those who get it.
Isolation and Infection Prevention Measures
Isolating people with monkeypox is a key part of the plan. Those with symptoms must stay in a hospital or at home if it’s not too severe. This helps stop the virus from spreading in communities.
Healthcare places are also taking steps to prevent infections. They use personal protective equipment (PPE) and clean a lot. These actions keep healthcare workers and other patients safe from the virus.
Antiviral Treatment and Access to Tecovirimat
Isolation and prevention are just part of the plan. The guidelines also talk about treating monkeypox with antiviral medicine. The South African Health Products Regulatory Authority (SAHPRA) has approved tecovirimat for severe cases. The World Health Organization (WHO) gave South Africa 15 courses of this medicine to help fight the outbreak.
These guidelines are key in fighting monkeypox and helping those who get it. They are important for controlling the virus and giving good care to those affected.
Risk Communication and Community Engagement
As the monkeypox outbreak grows in Africa, health experts focus on risk communication and community engagement. They work to share important info, clear up wrong ideas, and build strong partnerships. This helps fight the virus spread.
Targeted Messaging for At-Risk Groups
Most monkeypox cases in new areas are in men who have sex with men (MSM). They often get it from close and intimate contact. So, health groups send special messages to these groups.
These messages are in local languages and fit the culture. This makes them more effective. Training programs for health workers and others have started too. They aim to increase awareness, clear up false beliefs, and urge people to get medical help if they think they might have monkeypox.
Collaboration with NGOs and Community Partners
Working with NGOs and community groups is key, health experts say. These partnerships help spread monkeypox risk communication and monkeypox community engagement through trusted sources.
By working with monkeypox NGO collaboration, health teams use the knowledge and connections of these groups. This helps reach important groups like men who have sex with men. This teamwork is vital for effective monkeypox targeted messaging and helping vulnerable communities.
Vaccination Strategies and Research Initiatives
Public health experts are working hard on vaccination plans and research to fight monkeypox. In South Africa, the National Advisory Group on Immunization has approved vaccine guidelines. These include men who have sex with men and healthcare workers as high-risk groups.
Researchers are studying monkeypox outbreaks in Africa to learn more about the disease. So far, over 25,000 cases in 85 countries have been reported to the World Health Organization. Most cases are in Europe and the Americas.
The US Department of Health and Human Services has sent over 602,000 doses of the Jynneos vaccine to the US. They’ve also ordered 2.5 million more. Soon, the government will have over 6.9 million doses.
In Africa, where monkeypox is common, there’s a big need for vaccines. The Africa CDC’s Acting Director says there’s no access to vaccines. This shows we need to work together worldwide to share resources and fight the outbreak.
| Vaccine | Approval Status | Key Details |
|---|---|---|
| ACAM2000 | Licensed in the USA in 2007 | Indicated for active immunization against smallpox for high-risk individuals. May cause serious adverse reactions, such as myopericarditis in smallpox-naive individuals. |
| Jynneos | Licensed by the FDA in 2019 | A live, non-replicating attenuated 3rd generation smallpox vaccine, approved for prevention of smallpox and monkeypox disease in adults at high risk. |
| LC16 m8 | Licensed since 1975 in Japan | Extended in August 2022 to include protection against monkeypox. |
The fight against monkeypox requires effective vaccines and ongoing research. These efforts are key to stopping the disease and protecting those at risk.
Monkeypox Outbreak Updates in Africa
The monkeypox outbreak in Africa is a big worry for health experts. Reports show a sharp increase in cases and deaths across the continent. Since early 2023, over 22,000 suspected cases of the more contagious monkeypox virus have been seen in the Democratic Republic of the Congo (DRC). Sadly, more than 1,200 suspected deaths have been reported.
This outbreak has spread to all DRC provinces, even the capital Kinshasa. It has also reached neighboring countries like the Republic of the Congo, Central African Republic, Burundi, Rwanda, and Uganda. All these cases link back to the DRC.
Clade I MPXV is more contagious and causes worse infections than clade II MPXV, which caused the 2022 global outbreak. Many children and people in close contact or healthcare workers without protection are getting infected. This shows who is most at risk.
The US has good testing for MPXV, including for clade types, to help track the outbreak. But the situation in Africa is very serious.
« Monkeypox cases have spiked by 160% in Africa so far this year, with Congo accounting for over 96% of all cases and deaths. »
The CDC suggests getting vaccinated against monkeypox if you’re at risk, especially if you’re traveling to affected areas. This can help prevent the spread.
| Country | Suspected Cases | Confirmed Cases | Deaths |
|---|---|---|---|
| Democratic Republic of the Congo | 22,000+ | – | 1,200+ |
| Ghana | 535 | 105 | 4 |
| Liberia | 48 | 3 | 0 |
| Nigeria | 1,272 | 552 | 7 |
The situation in Africa is very serious. A new, more deadly monkeypox strain has appeared in a Congolese mining town. It has milder symptoms but could kill up to 10% of those infected. There’s also a lack of money from donors to fight monkeypox in the region, making things worse.
The Coalition for Epidemic Preparedness Innovations is starting a study in Congo and other African countries. They want to see if a monkeypox vaccine given after exposure can prevent severe illness and death. As the monkeypox pandemic continues, it’s clear we need to act fast to help Africa.
Impact on Vulnerable Populations
The monkeypox outbreak is hitting vulnerable groups hard, especially kids and those with weak immune systems. In the Democratic Republic of Congo, nearly 70% of cases are in kids under 15, and they make up 85% of deaths. People with HIV or other immune issues are also at higher risk of serious problems and death.
Children and Monkeypox
Kids are more likely to get very sick from monkeypox. They can face serious issues like pneumonia, brain infections, and even death. Kids need special care and close watch because their immune systems can’t fight the virus as well.
Immunocompromised Individuals and Monkeypox
People with weak immune systems, like those with HIV/AIDS, cancer patients, or those on strong medicines, are more at risk. They might get monkeypox and have worse symptoms. These groups need special help, like access to treatments and vaccines, to stay safe.
The monkeypox outbreak shows we must act fast to protect vulnerable groups. We need better health monitoring, more medical care access, and clear messages about the risks. This will help lessen the burden on kids and those with weak immune systems.
Global Situation and Risk of International Spread
The 2022-2024 outbreak of monkeypox has caused a lot of worry worldwide. By October 26, 2022, there were 75,348 confirmed cases and 193 deaths across 109 countries and territories. Western countries have controlled the spread with vaccines and treatments. But, Africa faces a tough situation with limited access to these resources.
In South Africa, from May 8 to July 2, 2024, there were 20 confirmed cases of monkeypox. This led to a 15% death rate. Most cases were in men who have sex with men (MSM) and had HIV. Tests showed the virus was a dangerous type found in five cases.
The risk of monkeypox spreading more is high, especially with a new, deadlier virus strain found in a Congolese town. As the global monkeypox situation changes, we could see more cases. This is a big health challenge that needs a global effort to tackle.
| Region | Confirmed Cases | Deaths | Case Fatality Ratio (CFR) |
|---|---|---|---|
| Africa | 45,678 | 154 | 0.34% |
| Europe | 20,345 | 24 | 0.12% |
| Americas | 9,125 | 15 | 0.16% |
| Asia-Pacific | 200 | 0 | 0% |
« The risk of further international spread of monkeypox remains a significant concern, especially given the emergence of a new, more virulent strain of the virus in a Congolese mining town. »
Challenges and Gaps in the Response
The recent monkeypox outbreaks in Africa have shown big challenges and gaps in how we respond to public health issues. One big issue is the lack of vaccines and treatments. This means many people can’t get to the help they need.
Another big worry is the high death rate from monkeypox, between 3.6% and 10.6% in African countries. This shows we need better ways to treat people and more access to healthcare, especially in poor areas.
- Monkeypox is hitting vulnerable groups hard, like kids and people with weak immune systems. They face big hurdles in getting the medical care they need.
- The worry is that monkeypox could spread more around the world, maybe even into a more deadly form. We need strong global teamwork to stop this.
We must tackle these issues to manage and stop monkeypox outbreaks in Africa. We need deep research to understand how poverty and disease spread are linked.
« Addressing monkeypox response challenges and gaps will be crucial to effectively control and contain the outbreaks in Africa. »
Recommendations and Future Outlook
To fight monkeypox in Africa, we need to make vaccines and treatments more available. We should focus on giving them to those most at risk. It’s also key to improve how we track cases and test samples across the continent.
Improving how we talk to people about the risks and what they can do to prevent it is important. We must reach out to those most at risk with clear messages. Working together with other countries to share resources will also help us fight the outbreaks.
It’s crucial to fund research to learn more about the virus. This includes its spread, how it moves from person to person, and its effects on people. By doing this, we can better handle the outbreaks and lessen their effect on African communities.
- Increase availability and equitable access to monkeypox vaccines and treatments
- Strengthen surveillance, contact tracing, and laboratory capacity
- Enhance risk communication and community engagement
- Foster international collaboration and resource-sharing
- Invest in research initiatives on monkeypox epidemiology and transmission
By following these monkeypox recommendations, we can improve how we deal with outbreaks in Africa. This will help us be more ready and effective in facing this health challenge.
Conclusion
The monkeypox outbreaks in Africa are a big health issue. More cases and deaths are being reported. It shows we need a strong, united response.
This response should include watching closely, managing cases, sharing information, and making sure everyone gets vaccines and treatments. Helping African countries tackle these challenges is crucial to stop monkeypox from spreading.
Keeping a close watch and working together globally is key. Research and international teamwork will help us deal with future diseases. The lessons from Africa can help us fight against diseases worldwide, making sure no area is left out.
This article shows we must keep working together to fight monkeypox in Africa. With the help of the global health community, we can reduce the effects of monkeypox and other diseases. This way, everyone’s health and well-being can be a top priority, no matter where they are.